← FDA Drug Approvals (Drugs@FDA)
ASPIRIN; OMEPRAZOLE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA INC · Approved 2023-01-20
Drug application
- FDA Application #
ANDA209791- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ASPIRIN; OMEPRAZOLE
- Generic name
- Aspirin
- Active ingredients
- ASPIRIN; OMEPRAZOLE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- TEVA PHARMS USA INC
- First approval
- 2023-01-20
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown